{"id":8613,"date":"2023-01-06T15:45:29","date_gmt":"2023-01-06T14:45:29","guid":{"rendered":"https:\/\/semmelweis.hu\/bioinformatika\/?page_id=8613"},"modified":"2024-04-25T11:52:56","modified_gmt":"2024-04-25T09:52:56","slug":"2021-ben-megjelent-publikaciok","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/bioinformatika\/publikaciok\/2021-ben-megjelent-publikaciok\/","title":{"rendered":"2021-ben megjelent publik\u00e1ci\u00f3ink"},"content":{"rendered":"

1: Nagy \u00c1, Munk\u00e1csy G, Gy\u0151rffy B<\/strong>. Pancancer survival analysis of cancer hallmark genes. Sci Rep. 2021 Mar 15;11(1):6047. doi: 10.1038\/s41598-021-84787-5. PMID:
\n33723286; PMCID: PMC7961001.<\/p>\n

2: Breitenecker K, Homolya M, Luca AC, Lang V, Trenk C, Petroczi G, Mohrherr J, Horvath J, Moritsch S, Haas L, Kurnaeva M, Eferl R, Stoiber D, Moriggl R, Bilban M, Obenauf AC, Ferran C, Dome B, Laszlo V, Gy\u0151rffy B<\/strong>, Dezso K, Moldvay J, Casanova E, Moll HP. Down-regulation of A20 promotes immune escape of lung adenocarcinomas. Sci Transl Med. 2021 Jul 7;13(601):eabc3911. doi: 10.1126\/scitranslmed.abc3911. PMID: 34233950; PMCID: PMC7611502.<\/p>\n

3: L\u00e1nczky A, Gy\u0151rffy B<\/strong>. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. J Med Internet Res. 2021 Jul 26;23(7):e27633. doi: 10.2196\/27633. PMID: 34309564; PMCID: PMC8367126.<\/p>\n

4: Andrijes R, Hejmadi RK, Pugh M, Rajesh S, Novitskaya V, Ibrahim M, Overduin M, Tselepis C, Middleton GW, Gy\u0151rffy B<\/strong>, Beggs AD, Berditchevski F. Tetraspanin 6 is a regulator of carcinogenesis in colorectal cancer. Proc Natl Acad Sci U S A. 2021 Sep 28;118(39):e2011411118. doi: 10.1073\/pnas.2011411118. PMID: 34521767; PMCID: PMC8488650.<\/p>\n

5: Beatson RE, Parente-Pereira AC, Halim L, Cozzetto D, Hull C, Whilding LM, Martinez O, Taylor CA, Obajdin J, Luu Hoang KN, Draper B, Iqbal A, Hardiman T, Zabinski T, Man F, de Rosales RTM, Xie J, Aswad F, Achkova D, Joseph CR, Ciprut S, Adami A, Roider HG, Hess-Stumpp H, Gy\u0151rffy B<\/strong>, Quist J, Grigoriadis A, Sommer A, Tutt ANJ, Davies DM, Maher J. TGF-\u03b21 potentiates V\u03b39V\u03b42 T cell adoptive immunotherapy of cancer. Cell Rep Med. 2021 Dec 21;2(12):100473. doi: 10.1016\/j.xcrm.2021.100473. PMID: 35028614; PMCID: PMC8714942.<\/p>\n

6: Prekovic S, Schuurman K, Mayayo-Peralta I, Manj\u00f3n AG, Buijs M, Yavuz S, Wellenstein MD, Barrera A, Monkhorst K, Huber A, Morris B, Lieftink C, Chalkiadakis T, Alkan F, Silva J, Gy\u0151rffy B<\/strong>, Hoekman L, van den Broek B, Teunissen H, Debets DO, Severson T, Jonkers J, Reddy T, de Visser KE, Faller W, Beijersbergen R, Altelaar M, de Wit E, Medema R, Zwart W. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nat Commun. 2021 Jul 16;12(1):4360. doi: 10.1038\/s41467-021-24537-3. PMID: 34272384; PMCID: PMC8285479.<\/p>\n

7: Menyh\u00e1rt O, Gy\u0151rffy B<\/strong>. Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis. Comput Struct Biotechnol J. 2021 Jan 22;19:949-960. doi: 10.1016\/j.csbj.2021.01.009. PMID: 33613862; PMCID: PMC7868685.<\/p>\n

8: Garcia-Garcia S, Rodrigo-Faus M, Fonseca N, Manzano S, Gy\u0151rffy B<\/strong>, Oca\u00f1a A, Bragado P, Porras A, Gutierrez-Uzquiza A. HGK promotes metastatic dissemination in prostate cancer. Sci Rep. 2021 Jun 10;11(1):12287. doi: 10.1038\/s41598-021-91292-2. PMID: 34112843; PMCID: PMC8192525.<\/p>\n

9: Milosevits G, M\u00e9sz\u00e1ros T, \u0150rfi E, Bakos T, Garami M, Kov\u00e1cs G, D\u00e9zsi L, Hamar P, Gy\u0151rffy B<\/strong>, Szab\u00f3 A, Sz\u00e9n\u00e1si G, Szebeni J. Complement-mediated hypersensitivity reactions to an amphotericin B-containing lipid complex (Abelcet) in pediatric patients and anesthetized rats: Benefits of slow infusion. Nanomedicine. 2021 Jun;34:102366. doi: 10.1016\/j.nano.2021.102366. Epub 2021 Feb 5. PMID: 33549818.<\/p>\n

10: Aslan M, Hsu EC, Garcia-Marques FJ, Bermudez A, Liu S, Shen M, West M, Zhang CA, Rice MA, Brooks JD, West R, Pitteri SJ, Gy\u0151rffy B<\/strong>, Stoyanova T. Oncogene- mediated metabolic gene signature predicts breast cancer outcome. NPJ Breast Cancer. 2021 Oct 28;7(1):141. doi: 10.1038\/s41523-021-00341-6. PMID: 34711841; PMCID: PMC8553750.<\/p>\n

11: Menyh\u00e1rt O, Fekete JT, Gy\u0151rffy B<\/strong>. Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies. Carcinogenesis. 2021 Jun 21;42(6):804-813. doi: 10.1093\/carcin\/bgab024. PMID: 33754151; PMCID: PMC8215594.<\/p>\n

12: Nagy \u00c1<\/strong>, Pongor S, Gy\u0151rffy B<\/strong>. Different mutations in SARS-CoV-2 associate with severe and mild outcome. Int J Antimicrob Agents. 2021 Feb;57(2):106272. doi: 10.1016\/j.ijantimicag.2020.106272. Epub 2020 Dec 23. PMID: 33347989; PMCID: PMC7755579.<\/p>\n

13: Alcaraz-Sanabria A, Caba\u00f1as Morafraile E, Fern\u00e1ndez-Hinojal G, Velasco G, P\u00e9rez-Segura P, Pandiella A, Gy\u0151rffy B<\/strong>, Oca\u00f1a A. Transcriptomic Mapping of Non- Small Cell Lung Cancer <i>K-RAS<\/i> p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates. Front Immunol. 2022 Feb 1;12:786069. doi: 10.3389\/fimmu.2021.786069. PMID: 35178045; PMCID: PMC8843839.<\/p>\n

14: Regan JL, Schumacher D, Staudte S, Steffen A, Lesche R, Toedling J, Jourdan T, Haybaeck J, Mumberg D, Henderson D, Gy\u0151rffy B<\/strong>, Regenbrecht CRA, Keilholz U, Sch\u00e4fer R, Lange M. RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence. iScience. 2021 May 24;24(6):102618. doi: 10.1016\/j.isci.2021.102618. PMID: 34142064; PMCID: PMC8185225.<\/p>\n

15: Periyasamy M, Singh AK, Gemma C, Farzan R, Allsopp RC, Shaw JA, Charmsaz S, Young LS, Cunnea P, Coombes RC, Gy\u0151rffy B<\/strong>, Buluwela L, Ali S. Induction of
\nAPOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-\u03baB. Oncogene. 2021 Feb;40(6):1077-1090. doi: 10.1038\/s41388-020-01583-7. Epub 2020 Dec 15. PMID: 33323971; PMCID: PMC7116738.<\/p>\n

16: Erokhin M, Chetverina O, Gy\u0151rffy B<\/strong>, Tatarskiy VV, Mogila V, Shtil AA, Roninson IB, Moreaux J, Georgiev P, Cavalli G, Chetverina D. Clinical Correlations of Polycomb Repressive Complex 2 in Different Tumor Types. Cancers (Basel). 2021 Jun 24;13(13):3155. doi: 10.3390\/cancers13133155. PMID: 34202528; PMCID: PMC8267669.<\/p>\n

17: Menyhart O, Weltz B, Gy\u0151rffy B.<\/strong> MultipleTesting.com: A tool for life science researchers for multiple hypothesis testing correction. PLoS One. 2021 Jun
\n9;16(6):e0245824. doi: 10.1371\/journal.pone.0245824. Erratum in: PLoS One. 2022 Sep 9;17(9):e0274662. PMID: 34106935; PMCID: PMC8189492.<\/p>\n

18: \u0150sz \u00c1, L\u00e1nczky A, Gy\u0151rffy B<\/strong>. Survival analysis in breast cancer using proteomic data from four independent datasets. Sci Rep. 2021 Aug 18;11(1):16787. doi: 10.1038\/s41598-021-96340-5. PMID: 34408238; PMCID: PMC8373859.<\/p>\n

19: Gleizes A, Triki M, Bonnet S, Baccari N, Jimenez-Dominguez G, Covinhes A, Pirot N, Blache P, Yuan R, Gy\u0151rffy B<\/strong>, Cavaill\u00e8s V, Lapierre M. RIP140 Represses Intestinal Paneth Cell Differentiation and Interplays with SOX9 Signaling in Colorectal Cancer. Cancers (Basel). 2021 Jun 26;13(13):3192. doi: 10.3390\/cancers13133192. PMID: 34206767; PMCID: PMC8268705.<\/p>\n

20: Kuehn J, Espinoza-Sanchez NA, Teixeira FCOB, Pav\u00e3o MSG, Kiesel L, Gy\u0151rffy B<\/strong>, Greve B, G\u00f6tte M. Prognostic significance of hedgehog signaling network-related
\ngene expression in breast cancer patients. J Cell Biochem. 2021 May;122(5):577-597. doi: 10.1002\/jcb.29886. Epub 2021 Jan 8. PMID: 33417295.<\/p>\n

21: Saiz-Ladera C, Baliu-Piqu\u00e9 M, Cimas FJ, Manzano A, Garc\u00eda-Barber\u00e1n V, Camarero SC, Hinojal GF, Pandiella A, Gy\u0151rffy B<\/strong>, Stewart D, Cruz-Hern\u00e1ndez JJ, P\u00e9rez Segura P, Ocana A. Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer. Front Oncol. 2021 Oct 6;11:714550. doi: 10.3389\/fonc.2021.714550. PMID: 34692491; PMCID: PMC8527851.<\/p>\n

22: Shafran JS, Jafari N, Casey AN, Gy\u0151rffy B<\/strong>, Denis GV. BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2021 Mar;24(1):268-277. doi: 10.1038\/s41391-020-0246-y. Epub 2020 Jul 21. PMID: 32690869; PMCID: PMC7855805.<\/p>\n

23: Noblejas-L\u00f3pez MDM, Baliu-Piqu\u00e9 M, Nieto-Jim\u00e9nez C, Cimas FJ, Morafraile EC, Pandiella A, Corbi \u00c1L, Gy\u0151rffy B<\/strong>, Oca\u00f1a A. Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation. Int J Mol Sci. 2021 Apr 7;22(8):3836. doi: 10.3390\/ijms22083836. PMID: 33917174;
\nPMCID: PMC8067872.<\/p>\n

24: Nagy \u00c1, Gy\u0151rffy B<\/strong>. muTarget: A platform linking gene expression changes and mutation status in solid tumors. Int J Cancer. 2021 Jan 15;148(2):502-511. doi:
\n10.1002\/ijc.33283. Epub 2020 Sep 17. PMID: 32875562.<\/p>\n

25: Bellanger A, Le DT, Vendrell J, Wierinckx A, Pongor LS, Solassol J, Lachuer J, Clezardin P, Gy\u0151rffy B<\/strong>, Cohen PA. Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer. Front Oncol. 2021 Jul 2;11:647269. doi: 10.3389\/fonc.2021.647269. PMID: 34277402; PMCID: PMC8283766.<\/p>\n

26: Listik E, Horst B, Choi AS, Lee NY, Gy\u0151rffy B<\/strong>, Mythreye K. A bioinformatic analysis of the inhibin-betaglycan-endoglin\/CD105 network reveals prognostic value in multiple solid tumors. PLoS One. 2021 Apr 5;16(4):e0249558. doi: 10.1371\/journal.pone.0249558. PMID: 33819300; PMCID: PMC8021191.<\/p>\n

27: Lehotzky A, Ol\u00e1h J, Fekete JT,<\/strong> Sz\u00e9n\u00e1si T, Szab\u00f3 E, Gy\u0151rffy B<\/strong>, V\u00e1rady G, Ov\u00e1di J. Co-Transmission of Alpha-Synuclein and TPPP\/p25 Inhibits Their Proteolytic Degradation in Human Cell Models. Front Mol Biosci. 2021 May 18;8:666026. doi: 10.3389\/fmolb.2021.666026. PMID: 34084775; PMCID: PMC8167055.<\/p>\n

28: D\u00edaz-Gil L, Bras\u00f3-Maristany F, Locatelli C, Centa A, Gy\u0151rffy B<\/strong>, Oca\u00f1a A, Prat A, Pandiella A. Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer. J Exp Clin Cancer Res. 2021 Oct 7;40(1):313. doi: 10.1186\/s13046-021-02098-z. PMID: 34620206; PMCID: PMC8496101.<\/p>\n

29: Panza S, Malivindi R, Caruso A, Russo U, Giordano F, Gy\u0151rffy B<\/strong>, Gelsomino L, De Amicis F, Barone I, Conforti FL, Giordano C, Bonofiglio D, Catalano S, And\u00f2
\nS. Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II\/AGTR1 Signaling in Glioblastoma Cells. Cancers (Basel). 2021 Sep 10;13(18):4555. doi: 10.3390\/cancers13184555. PMID: 34572782; PMCID: PMC8469998.<\/p>\n

30: Bartha \u00c1, Gy\u0151rffy B.<\/strong> TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int J Mol Sci. 2021 Mar 5;22(5):2622. doi: 10.3390\/ijms22052622. PMID: 33807717; PMCID: PMC7961455.<\/p>\n

31: Fuentes-Antr\u00e1s J, Alcaraz-Sanabria AL, Morafraile EC, Noblejas-L\u00f3pez MDM, Gal\u00e1n-Moya EM, Baliu-Pique M, L\u00f3pez-Cade I, Garc\u00eda-Barber\u00e1n V, P\u00e9rez-Segura P,
\nManzano A, Pandiella A, Gy\u0151rffy B<\/strong>, Oca\u00f1a A. Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery
\nin Breast Cancer. Cancers (Basel). 2021 Feb 17;13(4):833. doi: 10.3390\/cancers13040833. PMID: 33671201; PMCID: PMC7922122.<\/p>\n

32: Noblejas-L\u00f3pez MDM, L\u00f3pez-Cade I, Fuentes-Antr\u00e1s J, Fern\u00e1ndez-Hinojal G, Esteban-S\u00e1nchez A, Manzano A, Garc\u00eda-S\u00e1enz J\u00c1, P\u00e9rez-Segura P, La Hoya M,
\nPandiella A, Gy\u0151rffy B<\/strong>, Garc\u00eda-Barber\u00e1n V, Oca\u00f1a A. Genomic Mapping of Splicing- Related Genes Identify Amplifications in <i>LSM1<\/i>, <i>CLNS1A,<\/i> and
\n<i>ILF2<\/i> in Luminal Breast Cancer. Cancers (Basel). 2021 Aug 16;13(16):4118. doi: 10.3390\/cancers13164118. PMID: 34439272; PMCID: PMC8391113.<\/p>\n

33: Gy\u0151rffy B<\/strong>. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct
\nBiotechnol J. 2021 Jul 18;19:4101-4109. doi: 10.1016\/j.csbj.2021.07.014. PMID: 34527184; PMCID: PMC8339292.<\/p>\n

34: Siddharth S, Parida S, Muniraj N, Hercules S, Lim D, Nagalingam A, Wang C, Gyorffy B<\/strong>, Daniel JM, Sharma D. Concomitant activation of GLI1 and Notch1
\ncontributes to racial disparity of human triple negative breast cancer progression. Elife. 2021 Dec 10;10:e70729. doi: 10.7554\/eLife.70729. PMID: 34889737; PMCID: PMC8664295.<\/p>\n

35: Hargadon KM, Gy\u0151rffy B<\/strong>, Strong EW. The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer
\ngenome atlas. Cancer Genet. 2021 Jun;254-255:58-64. doi: 10.1016\/j.cancergen.2021.02.005. Epub 2021 Feb 13. PMID: 33636524.<\/p>\n

36: Rojas K, Baliu-Piqu\u00e9 M, Manzano A, Saiz-Ladera C, Garc\u00eda-Barber\u00e1n V, Cimas FJ, P\u00e9rez-Segura P, Pandiella A, Gy\u0151rffy B<\/strong>, Ocana A. In silico transcriptomic
\nmapping of integrins and immune activation in Basal-like and HER2+\u2009breast cancer. Cell Oncol (Dordr). 2021 Jun;44(3):569-580. doi: 10.1007\/s13402-020-00583-9. Epub 2021 Jan 19. PMID: 33469836.<\/p>\n

37: Grillo PK, Gy\u0151rffy B<\/strong>, G\u00f6tte M. Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients. J Cancer Res Clin Oncol. 2021 Jul;147(7):1937-1955. doi: 10.1007\/s00432-021-03597-4. Epub 2021 Mar 19. PMID: 33742285; PMCID: PMC8164625.<\/p>\n

38: Nagalingam A, Siddharth S, Parida S, Muniraj N, Avtanski D, Kuppusamy P, Elsey J, Arbiser JL, Gy\u0151rffy B<\/strong>, Sharma D. Hyperleptinemia in obese state renders
\nluminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB. NPJ Breast Cancer. 2021 Aug 13;7(1):105. doi:
\n10.1038\/s41523-021-00314-9. PMID: 34389732; PMCID: PMC8363746.<\/p>\n

39: Kozma GT, M\u00e9sz\u00e1ros T, Bakos T, Hennies M, Bencze D, Uzonyi B, Gy\u0151rffy B<\/strong>, Cedrone E, Dobrovolskaia MA, J\u00f3zsi M, Szebeni J. Mini-Factor H Modulates
\nComplement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm. Front Immunol. 2021 Apr
\n28;12:642860. doi: 10.3389\/fimmu.2021.642860. PMID: 33995361; PMCID: PMC8113956.<\/p>\n

40: Bozs\u00e1nyi S, Varga NN, Farkas K, B\u00e1nv\u00f6lgyi A, L\u0151rincz K, Lihacova I, Lihachev A, Plorina EV, Bartha \u00c1<\/strong>, Jobb\u00e1gy A, Kuroli E, Paragh G, Holl\u00f3 P, Medvecz M, Kiss
\nN, Wikonk\u00e1l NM. Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma. J Clin Med. 2021 Dec 30;11(1):189. doi: 10.3390\/jcm11010189. PMID: 35011930; PMCID: PMC8745435.<\/p>\n","protected":false},"excerpt":{"rendered":"

1: Nagy \u00c1, Munk\u00e1csy G, Gy\u0151rffy B. Pancancer survival analysis of cancer hallmark genes. Sci Rep. 2021 Mar 15;11(1):6047. doi: 10.1038\/s41598-021-84787-5. PMID: 33723286; PMCID: PMC7961001. 2: Breitenecker K, Homolya M, Luca AC, Lang V, Trenk C, Petroczi G, Mohrherr J, Horvath J, Moritsch S, Haas L, Kurnaeva M, Eferl R, Stoiber D, Moriggl R, Bilban …<\/p>\n","protected":false},"author":102018,"featured_media":0,"parent":8610,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-8613","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/users\/102018"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/comments?post=8613"}],"version-history":[{"count":10,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8613\/revisions"}],"predecessor-version":[{"id":10236,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8613\/revisions\/10236"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8610"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/media?parent=8613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/categories?post=8613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/tags?post=8613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}